Literature DB >> 19853082

Choice of conduit for the right coronary system: 8-year analysis of Radial Artery Patency and Clinical Outcomes trial.

Ignatius E Hadinata1, Philip A R Hayward, David L Hare, George S Matalanis, Siven Seevanayagam, Alexander Rosalion, Brian F Buxton.   

Abstract

BACKGROUND: Previous reports have supported the use of bilateral internal thoracic arteries to revascularize the left coronary circulation. If this becomes standardized practice, the optimal conduit for the right coronary system remains to be established. Our objective is to compare the performance of the radial artery versus the saphenous vein when used to graft the right coronary artery or its branches during an 8-year period after primary coronary artery bypass graft surgery.
METHODS: The Radial Artery Patency and Clinical Outcomes study is a randomized controlled trial comparing radial artery, saphenous vein, and free right internal thoracic artery. Of the 621 patients enrolled in the study, 465 patients received a graft to the right coronary artery or its branches. The retrospectively compiled database was used to establish patency rates and clinical events among these patients.
RESULTS: Absolute graft patency rates were as follows: radial artery, 86.9% of 68 (95% confidence interval, 76.6% to 93.1%); and saphenous vein, 81.2% of 197 (95% confidence interval, 75.1% to 86.1%). Noninferiority tests show that absolute radial patency to saphenous patency is at least 0.9526 (p = 0.025). Kaplan-Meier estimates of angiographic outcomes show no significant difference (log rank p = 0.22). Cardiac events in the right coronary territory occurred in the radial artery group (1.79%) versus the saphenous vein group (4.93%; p = 0.26). Overall mortality was 8.03% in the radial artery group versus 12.5% in the saphenous vein group (p = 0.23).
CONCLUSIONS: The radial artery patency is at least comparable to that of the saphenous vein when grafted to the right coronary artery or its branches. The paucity of clinical events in both grafts is notable. Selection of best conduit may therefore be made according to other factors.

Entities:  

Mesh:

Year:  2009        PMID: 19853082     DOI: 10.1016/j.athoracsur.2009.06.010

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

1.  The history of arterial revascularization: from Kolesov to Tector and beyond.

Authors:  Brian F Buxton; Sean D Galvin
Journal:  Ann Cardiothorac Surg       Date:  2013-07

Review 2.  Radial artery graft vs. saphenous vein graft for coronary artery bypass surgery : which conduit offers better efficacy?

Authors:  H Zhang; Z W Wang; H B Wu; X P Hu; Z Zhou; P Xu
Journal:  Herz       Date:  2013-06-21       Impact factor: 1.443

3.  eComment. The best graft for the right coronary artery.

Authors:  Jamil Hajj-Chahine; Christophe Jayle; Jacques Tomasi; Pierre Corbi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08

4.  Impact of the size mismatch between saphenous vein graft and coronary artery on graft patency.

Authors:  Yoshitaka Yamane; Naomichi Uchida; Shuhei Okubo; Hironobu Morimoto; Shogo Mukai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-08-02

Review 5.  Role of smooth muscle cells in coronary artery bypass grafting failure.

Authors:  Kerry Wadey; Joshua Lopes; Michelle Bendeck; Sarah George
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

Review 6.  Strategies for the coronary surgeon to remain "competitive and co-operative" in the PCI era.

Authors:  George Jose Valooran; Shiv Kumar Nair; Krishnan Chandrasekharan
Journal:  Indian Heart J       Date:  2015-07-08

7.  Second best conduit-is it the tag or patency that counts?

Authors:  Pradeep Narayan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-01-18

8.  Fatty acids composition of aorta and saphenous vein tissues in patients with coronary artery diseases.

Authors:  Mirhamid Paytakhti Oskouei; Masoud Pezeshkian; Naser Safaie; Masoud Darabi; Amir Fattahi; Hossain Bijanpour; Maghsod Shaaker; Ahmad Reza Jodati; Mohammad Nouri
Journal:  J Cardiovasc Thorac Res       Date:  2017-06-12

9.  In Situ Blood Vessel Regeneration Using SP (Substance P) and SDF (Stromal Cell-Derived Factor)-1α Peptide Eluting Vascular Grafts.

Authors:  Muhammad Shafiq; Qiuying Zhang; Dengke Zhi; Kai Wang; Deling Kong; Dong-Hwee Kim; Soo Hyun Kim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-31       Impact factor: 8.311

10.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.